Introduction {#sec1}
============

The severe form of acute pancreatitis (AP) is classified as severe AP (SAP) and is associated with a mortality rate as high as 30% \[[@B1]\]. Management of SAP is complicated due to the lack of knowledge of the pathogenesis, which increases the uncertainties in the prognosis and thus impedes the effective therapy \[[@B2]\]. SAP presents a serious gastrointestinal (GI) tract or ileal obstruction during the early stage of the disease \[[@B3]\]. However, conventional treatment often overlooks the pivotal role of the intestine in SAP. Recent evidence suggests that bacterial translocation and intestinal sepsis play key roles in SAP \[[@B4],[@B5]\]. Thus, novel therapies for SAP aiming at limiting intestinal injury are being developed, including use of several antioxidant and anti-cytokine agents \[[@B6]--[@B8]\]. Nevertheless, the definite relationship between SAP and the intestine remains obscure.

Hydrogen sulphide (H~2~S), at normal temperature, is a colourless gas with a strong odour and performs many physiological functions \[[@B9]\]. It is predominantly produced by the activation of cystathionine-γ-lyase (CSE), cystathionine-β-synthase (CBS) and 3-mercaptopyruvate sulphurtransferase (3-MST). H~2~S is present in many tissues of the body and initiates pharmacophysiological responses in most organ systems \[[@B10],[@B11]\]. In the recent decade, particular interest in the role of H~2~S in the GI tract is emerging based on the finding that it is produced both by GI tissues and generated in large quantities by bacterial flora in the lumen of the gut \[[@B12]\]. The production of H~2~S has been shown to inhibit GI motility in a fish model \[[@B12]\]. Interestingly, the synthesis of H~2~S induced in the GI system also serves as an inhibitor of the inflammatory response \[[@B13]\].

Although three enzymes are involved in the synthesis of H~2~S, CSE is reported to be the major enzyme in the production of H~2~S in peripheral tissues \[[@B14]\]. Previous studies have implicated a role for PI3K/Akt/*Sp1* signalling in the regulation of CSE \[[@B15]\]. In the present study, we investigated the role of H~2~S and its possible role in SAP in a rat model.

Materials and methods {#sec2}
=====================

Chemicals, cell cultures and animals {#sec2-1}
------------------------------------

Antibodies against CSE, CBS, PI3K, pPI3K, Akt, p-Akt, *Sp1* and GAPDH were purchased from Abcam. PI3K inhibitor LY294002 was purchased from Sigma. Rat colonic muscle cells (CMCs) were separated from the mucous membrane of the proximal colon and cultured in a solution containing 0.15% collagenase II, 0.1% trypsin inhibitor and 0.25% FBS at 37°C for subsequent experiments. Identification of CMCs was performed with immunofluorescent validation of α-actin, as described below. Adult male Wistar rats (weighing 200--250 g) were provided by the Guilin Medical University Experiment Center and maintained in cages at room temperature (20--25°C) with constant humidity (55 ± 5%) with free access to food and water *ad libitum*. All animal experiments were conducted in accordance with the Institutional Animal Ethics Committee and Animal Care Guidelines for the Care and Use of Laboratory Animals of Guilin Medical University.

Induction of SAP in a rat model {#sec2-2}
-------------------------------

Thirty rats were selected and randomly divided into three groups (ten in each group): the sham group where rats underwent a laparotomy and flip of duodenum and pancreas like the animals in the SAP group but without being injected the corresponding agents, the SAP group where rats underwent a laparotomy and were then injected with 5% sodium taurocholate into the bile and the ducts using a microinjection pump (1 ml/kg, 0.1 ml/min) for 10 min followed by suturing of the incision and the SAP + PAG (propargylglycine) group where rats underwent the same surgical procedures as the SAP group but with 30 μmol/kg PAG (inhibitor of CSE) injected into the bile and the pancreatic ducts in addition to the sodium taurocholate. All the rats were subcutaneously injected with 10 ml of normal saline and were then fasted for 24 h before subsequent experiments.

Treatment of CMCs with TNF-α and IL-6 {#sec2-3}
-------------------------------------

To explore the role of inflammation in modulating CSE and associated pathways, CMCs were administrated with 5% plasma from rats with SAP, 10 μg/l of tumour necrosis factor-α (TNF-α) or 10 μg/l of interleukin-6 (IL-6). The expressions of CSE, CBS, *Sp1* and PI3K/Akt were then detected using real-time quantitative PCR (RT-qPCR) and Western blotting.

Knockdown of *Sp1* gene in CMCs {#sec2-4}
-------------------------------

A specific *Sp1* siRNA (5′-GCAACAUGGGAAUUAUGAATT-3′) was constructed by GenePharma (Shanghai) and ligated into the shuttle vector pGL3. Transfection was conducted using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. CMCs were divided into four groups: the NC group with healthy CMCs, the LY294002 group with healthy CMCs that were incubated with 5.0 μmol/l of LY294002 for 24 h, the vector group with healthy CMCs that were transfected with the blank pGL3 vector and the si-*Sp1* group with healthy CMCs that were transfected with the pGL3 vector and *Sp1* siRNA. Each treatment was represented by three replicates.

Measurement of intestinal motility {#sec2-5}
----------------------------------

The intestinal motilities of experimental rats were represented by the number of bowel movements. The measurements were performed 1 h before SAP induction and 4, 8, 12, 16, 20, 24 h after SAP induction, by two independent observers who were blind to the experimental design.

Detection of the SAP-induced inflammatory response {#sec2-6}
--------------------------------------------------

After the intestinal motility measurements were completed, rats were sacrificed and plasma was collected. The inflammatory cytokines that were produced, including TNF-α and IL-6 were measured using CUSABIO ELISA kits, according to the manufacturer's instructions.

Immunohistochemical detection {#sec2-7}
-----------------------------

For the immunohistochemical assay, paraffin sections of colonic muscle tissues from rats in the different groups were placed in 60°C for 2 h, followed by incubation with dimethylbenzene for dewaxing. The sections were then hydrated with different concentrations of alcohol (95% for 2 min, 85% for 2 min and 75% for 5 min) and washed with ddH~2~O for 2 min. Sections were then fixed using 3% H~2~O~2~ for 15 min and washed with PBS three times. They were then incubated with primary antibodies against CSE (Abcam, diluted 1:200) and CBS (Abcam, diluted 1:500) at 37°C for 30 min and incubated at 4°C overnight. After three cycles of 0.01 M PBS washes, 5 min for each cycle, the secondary antibody (1:200) was added to the sections and placed at 37°C for 30 min followed by another five cycles of PBS washes. HRP-labelled avidin was then added and incubated with the sections at 37°C for 30 min before addition of DAB. The reaction was kept for 3--10 min and then stopped by ddH~2~O. Slides were re-stained using haematoxylin and dehydrated. Finally, the slides were scanned using an Aperio ScanScope GL (Aperio Technologies, Vista, CA, U.S.A.) at 200× magnification.

RT-qPCR {#sec2-8}
-------

Whole RNA was extracted from tissues or cells in the different groups using RNA simple Total RNA Kit, according to the manufacturers' instructions (Cat. No. DP419, TIANGEN, Beijing, China). *GAPDH* was selected as the internal reference gene. cDNA templates were prepared from total RNA using Super M-MLV Reverse Transcriptase (Cat. No. RP6502, BioTeke, Beijing, China), and the RT-qPCR reaction mixture with a final volume of 20 μl contained 10 μl of SYBR Premix Ex Taq II, 0.5 μl of each primer set (Supplementary Table S1), 1 μl of the cDNA template and 8 μl of RNase-free H~2~O. Thermal cycling parameters for amplification were as follows: a denaturation step at 95°C for 10 min, followed by 40 cycles at 95°C for 10 s, 60°C for 20 s and 72°C for 30 s. Relative expression levels of targeted genes were calculated with Data Assist Software version 3.0 (Applied Biosystems/Life Technologies), according to the expression 2^−ΔΔ*C**t*^.

Western blotting assay {#sec2-9}
----------------------

Whole protein was extracted from the different cells using the Total Protein Extraction Kit, according to the manufacturer's instructions (Cat. No. WLA019, Wanleibio, China). GAPDH was used as an internal reference protein. Concentrations of protein samples were determined using the BCA method and 40 μg of protein was subjected to 10% SDS/PAGE. After transferring targeted proteins on to PVDF sheets, the membranes were washed with TTBS for 5 min and then incubated with skimmed milk powder solution for 1 h. Primary antibodies against CSE (Abcam, diluted 1:500), CBS (Abcam, diluted 1:1000), PI3K (Abcam, diluted 1:2000), pPI3K (Abcam, diluted 1:1000), Akt (Abcam, diluted 1:2000), p-Akt (Abcam, diluted 1:1000), *Sp1* (Abcam, diluted 1:2500) or GAPDH (1:2000) were incubated with membranes at 4°C overnight. After additional four washes using TTBS, the secondary HRP IgG antibody (1:5000) was added and incubated with the membranes for 45 min at 37°C. After six washes with TTBS, the blots were developed using Beyo ECL Plus reagent and the results were recorded in the Gel Imaging System. The relative expression levels of GREM1 and GLI3 in different samples were calculated with Gel-Pro-Analyzer (Media Cybernetics, U.S.A.).

Immunofluorescent assay {#sec2-10}
-----------------------

The distribution and expression of CSE after *Sp1* knockdown was detected with immunofluorescent microscopy. In brief, the treated cells were seeded into 14-well chambers, washed with PBS, fixed with 4% paraformaldehyde for 15 min. Then the cells were permeabilized with 0.5% Triton X-100 for 30 min. The cells were washed with PBS for three cycles, 5 min for each cycle and were blocked in 10% goat serum for 15 min. Primary rabbit polyclonal antibody to CSE (Abcam, diluted 1:50) was then added and the cells were incubated overnight at 4°C in 1% goat serum. Staining was performed by incubating the cells with Alexa Fluor 594--conjugated secondary antibodies for 1 h at room temperature. After incubation with the secondary antibody, cells were washed and then stained with DAPI for 5 min at room temperature. After three cycles of 5-min washes with PBS buffer, the slides were fixed and imaged with the fluorescent microscope at 200× magnification.

Statistical analysis {#sec2-11}
--------------------

All the data were expressed in the form of mean ± S.D. Comparison of means among multiple groups was done by one-way ANOVA. Tukey test was provided where equal variances were assumed, while Tamhane's T2 test was used where equal variances were not assumed. Statistical significance was defined as *P*\<0.05. All graphs were plotted and statistical analyses performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA).

Results {#sec3}
=======

H~2~S is involved in the suppression of intestinal motility {#sec3-1}
-----------------------------------------------------------

The number of bowel movements in rats from the different groups was recorded to evaluate intestinal motility. As shown in [Figure 1](#F1){ref-type="fig"}, before SAP induction, there was no difference in the number of bowel movements among the different groups. However, after SAP was induced, the number of bowel movements in the SAP group was significantly reduced compared with that in the sham (*P*\<0.05) group. To elucidate whether the loss of intestinal motility was due to the production of H~2~S, rats were administered with PAG, which inhibits the production of H~2~S. We found that the suppression of H~2~S by PAG significantly increased intestinal motility, compared with the SAP group (*P*\<0.05), suggesting a critical role for H~2~S in intestinal motility in rats with SAP.

![The number of bowels over different time periods.\
The number of bowel movements. Intestinal motility was determined by counting the number of bowel movements. \*, significantly different from the sham group, *P*\<0.05. \#, significantly different from the SAP group, *P*\<0.05 (*n*=10, each group).](bsr-2016-0483i001){#F1}

H~2~S is associated with SAP-induced up-regulation of the inflammatory response and the synthesis of CSE and CBS {#sec3-2}
----------------------------------------------------------------------------------------------------------------

Since H~2~S enhances inflammation, we tested the levels of inflammatory cytokines in the plasma of the rats using ELISA. Of note, expressions of TNF-α and IL-6 were dramatically increased in association with the SAP induction ([Figure 2](#F2){ref-type="fig"}). Moreover, the decrease in H~2~S impaired the secretion of TNF-α and IL-6. In a similar fashion, SAP promoted the synthesis of CSE and CBS, whereas the suppression of H~2~S by PAG reduced the levels of CSE and CBS ([Figure 3](#F3){ref-type="fig"}A-C), indicating that H~2~S plays a favourable role in the inflammatory response induced by SAP.

![Expressions of inflammatory cytokines.\
Expressions of inflammatory cytokines by ELISA. (**A**) TNF-α. (**B**) IL-6. Concentrations of TNF-α and IL-6 in plasma of rats were increased after SAP induction. Suppression of H~2~S impeded the levels of inflammatory cytokines. \*, significantly different from the sham group, *P*\<0.05. \#, significantly different from the SAP group, *P*\<0.05 (*n*=10, each group).](bsr-2016-0483i002){#F2}

![H~2~S synthesizing enzymes are induced by SAP.\
(**A**) Immunohistochemical detection. (**B**) Levels of CBS by quantitative RT-PCR. (**C**) Levels of CSE by quantitative RT-PCR. Images of immunohistochemical detection and quantitative RT-PCR were used to validate the expression of CSE and CBS. SAP significantly increased the expressions of CSE and CBS. PAG down-regulated the levels of CSE. \*, significantly different from the sham group, *P*\<0.05. \#, significantly different from the SAP group, *P*\<0.05 (*n*=10, each group).](bsr-2016-0483i003){#F3}

PI3K/Akt-mediated *Sp1* signalling pathway is activated by SAP {#sec3-3}
--------------------------------------------------------------

To study the molecular mechanism of H~2~S in SAP, we investigated the signalling pathway of PI3K/Akt-mediated *Sp1*. Similar to the results from [Figure 3](#F3){ref-type="fig"}B, Western blotting data showed that the expressions of CSE and CBS proteins in the SAP group were elevated compared with those in the sham group, but were reduced after H~2~S was inhibited in the SAP + PAG group ([Figure 4](#F4){ref-type="fig"}A). Notably, phosphorylation levels of PI3K and Akt, were dramatically increased in the SAP and SAP + PAG groups, (which then up-regulated the expression of *Sp1*), compared with the sham group. There was no significant difference in PI3K/Akt/*Sp1* expressions between the SAP and SAP + PAG groups, suggesting a potential upstream regulator of PI3K/Akt/*Sp1* that produces H~2~S, through the modulation of CSE ([Figure 4](#F4){ref-type="fig"}B,C).

![SAP activated *Sp1* signalling pathway.\
The expressions of CSE, CBS and PI3K/Akt/*Sp1* in plasma of rats by Western blotting. (**A**) The expressions of CSE, CBS proteins. (**B**) The expressions of PI3K, p-PI3K, Akt, p-Akt. (**C**) The levels of *Sp1* protein. GAPDH was set as inner reference and five samples in each group were detected.](bsr-2016-0483i004){#F4}

SAP induced the production of H~2~S by initiating the inflammatory response {#sec3-4}
---------------------------------------------------------------------------

We used CMCs to explore the interaction between the inflammatory response and H~2~S production. We found that treating the CMCs with 5% plasma from SAP rats, TNF-α or IL-6, all contributed to the significantly increased expressions of CSE and CBS, compared with the NC group (*P*\<0.05) ([Figure 5](#F5){ref-type="fig"}A,B). Also, PI3K/Akt/*Sp1* signalling in CMCs was significantly activated after the treatment with 5% plasma from SAP rats, TNF-α or IL-6 compared with the NC group (*P*\<0.05) ([Figure 5](#F5){ref-type="fig"}C--E). The results confirmed our hypothesis that H~2~S production was induced by inflammatory cytokines associated with SAP symptoms. Considering that CSE is the major H~2~S-producing enzyme in peripheral tissues, the expression and distribution of the enzyme was further detected with an immunohistochemical assay ([Figure 6](#F6){ref-type="fig"}), and the results were consistent with our RT-qPCR data in [Figure 5](#F5){ref-type="fig"}A. Together, these results suggest that inflammatory cytokines, IL-6 or TNF-α increase the expression of H~2~S and CSE, in CMCs.

![Plasma from SAP rats, TNF-α or IL-6 promoted production of H~2~S.\
The expressions of inflammatory cytokines in CMCs treated with 5% plasma from rats with SAP, TNF-α or IL-6. (**A**) Relative fold of CSE by qRT-PCR. (**B**) Relative fold of CBS by qRT-PCR. (**C**) Relative fold of *Sp1* by qRT-PCR. (**D**) The expressions of PI3K, pPI3K, Akt, p-Akt by Western blotting. (**E**) The expressions of *Sp1* by Western blotting. GAPDH was set as an inner reference. \*, significantly different from the sham group, *P*\<0.05. \#, significantly different from the SAP group, *P*\<0.05 (*n*=3, each group).](bsr-2016-0483i005){#F5}

![Plasma from SAP rats, TNF-α or IL-6 induced expression of CSE.\
Expression and distribution of CSE in CMCs treated with SAP plasma, TNF-α or IL-6 by immunohistochemical assay (200× magnification).](bsr-2016-0483i006){#F6}

SAP up-regulated the production of H~2~S via PI3K/Akt/*Sp1*l signalling pathway {#sec3-5}
-------------------------------------------------------------------------------

To validate that the PI3K/Akt-mediated *Sp1* modulates CSE in CMCs, we blocked the expression of PI3K with either an inhibitor, LY294002 or specific siRNA, si-*Sp1* vector. Our data showed that the activation of PI3K/Akt/*Sp1* signalling was impeded in CMCs with the treatment of LY294002 or si-*Sp1* ([Figure 7](#F7){ref-type="fig"}A,C,D). Moreover, the suppression of PI3K/Akt/*Sp1* signalling pathway by LY294002 or si-*Sp1* also down-regulated the levels of CSE in CMCs treated with plasma from SAP rats ([Figure 7](#F7){ref-type="fig"}B,D). In addition, the immunohistochemical analysis revealed that blocking PI3K/Akt/*Sp1* inhibited CSE synthesis after the induction of SAP ([Figure 8](#F8){ref-type="fig"}A,B). All together, our data demonstrated that the expression of CSE is associated with PI3K/Akt/*Sp1* and suggested that the production of H~2~S is induced by SAP via the activation of the PI3K/Akt/*Sp1* signalling pathway.

![Expressions of CSE and levels of PI3K/Akt/*Sp1* in CMCs treated with LY294002 and si-*Sp1*.\
(**A**) The levels of *Sp1* by qRT-PCR. (**B**) The level of CSE by qRT-PCR. (**C**) The expressions of PI3K, pPI3K, Akt, p-Akt by Western blotting. (**D**) The expressions of *Sp1* by Western blotting. Inhibition of PI3K/Akt/*Sp1* signalling suppressed the expression of CSE. \*, *P*\<0.05, significantly different between the two groups (*n*=3, each group).](bsr-2016-0483i007){#F7}

![Expressions of CSE in CMCs treated with LY294002 and si-*Sp1* detected by immunohistochemical assay.\
Expression and distribution of CSE in SAP model was limited by administration of (**A**) PI3K inhibitor LY294002 and (**B**) *Sp1* siRNA as detected by immunohistochemical assay (200× magnification).](bsr-2016-0483i008){#F8}

Discussion {#sec4}
==========

The trans-sulphuration pathway is an important mechanism, by which cells provide cysteine to synthesize the cellular redox-controlling molecules and protect against damages induced by reactive oxygen species (ROS) \[[@B16]\]. Deficiencies in the trans-sulphuration pathway result in the overproduction of pro-inflammatory factors and cause a chronic inflammatory process, associated with the development of tumours and various diseases \[[@B16]\]. H~2~S is the third member of the gasotransmitter family and is endogeneously synthesized by CSE and CBS in the trans-sulphuration pathway \[[@B17]\]. H~2~S is increasingly recognized as a functionally relevant mediator with a number of physiological functions and abnormal production of H~2~S has been demonstrated to be associated with inflammation in mammalian tissues \[[@B18],[@B19]\]. However, the interaction between H~2~S production and inflammation is complicated. In a study by Wallace et al. \[[@B13]\], the authors concluded that H~2~S played a protective role in the GI system by inhibiting the production of TNF-α and leucocyte adherence to the vascular endothelium. In contrast, Tamizhselvi et al. \[[@B19]\] reported that H~2~S is an inducer of the inflammatory response in rats with AP. Thus, the exact function and mechanism of H~2~S in the onset of SAP remains unknown. In the current study, the role of H~2~S in the development of SAP was further studied by targeting its effect on inflammation and intestinal motility.

Consistent with numerous previous studies, the induction of SAP initiates the expression of CSE and CBS \[[@B19]--[@B21]\], that leads to the production of H~2~S. Nevertheless, it was surprising to find that the augmented release of H~2~S in the current study was not only associated with the suppression of intestinal motility but also with the suppression of inflammation. After inhibiting the activity of CSE *in vivo* by PAG, which suppressed the production of H~2~S, the levels of TNF-α and IL-6 in the plasma were significantly increased. These results suggested an association between H~2~S and inflammatory cytokines. Therefore, CMCs isolated from rats were incubated with SAP plasma, TNF-α and IL-6 to investigate the role of H~2~S in SAP. We found that SAP plasma, TNF-α and IL-6, all induced the expression of CSE and CBS and enhanced the production of H~2~S. This finding is in agreement with previous reports that H~2~S plays a pro-inflammatory role in SAP \[[@B19]--[@B21]\].

In addition to the the reduced production of H~2~S, the intestinal motility of rats with SAP were remarkably inhibited, consistent with previous reports regarding the effect of H~2~S on the GI system \[[@B12],[@B22],[@B23]\]. The motility of the intestinal tract depends on the contraction of smooth muscles, which are regulated by ATP-sensitive K^+^ (K~ATP~) channels \[[@B24],[@B25]\]. Typically, in smooth muscle cells, opening of the K~ATP~ channels will hyperpolarize the cell membrane, inactivate voltage-dependent L-type Ca^2+^ channels, and result in cell relaxation and blood vessel dilation by reducing intracellular free Ca^2+^ concentration \[[@B26]\]. As was previously reported, activation of K~ATP~ channels can be initiated by endogeneous and exogenous production of H~2~S \[[@B27]--[@B29]\]. Although cell membrane potential was not tested in the current study due to the limitation of experimental instruments, it is reasonable to speculate that the H~2~S produced in SAP patients was first induced by an inflammatory response and subsequently suppressed the colonic motility by activating the opening of K~ATP~ channels. Therefore, application of H~2~S in clinics should depend on a comprehensive assessment of the toxicity and side effects of the agent.

Underlying the inflammatory pathway associated with H~2~S production, the expression of *Sp1*, a critical regulator of CSE, was inhibited by a specific siRNA in our study. It is commonly recognized that the production of H~2~S is catalysed by CSE, CBS and 3-MST, of which CSE is reported to be the major H~2~S-producing enzyme in peripheral tissues \[[@B14]\]. A previous study showed that CSE expression is regulated by PI3K/Akt pathways via *Sp1* \[[@B15]\]. Given the multiple functions of the PI3K/Akt pathway in diverse biological processes including inflammation, the possibility of PI3K/Akt pathway in modulating H~2~S production in SAP was assessed. Previous work showed that both IL-6 and TNF-α contributed to the activity of PI3K/Akt pathway through multiple mechanisms \[[@B30], [@B31]\]. Based on our data, both SAP-induced inflammation *in vivo* and administering cytokines *in vitro* initiated the activation of the PI3K/Akt pathway. Moreover, the up-regulated activities of PI3K and Akt were shown to increase the synthesis of CSE through the regulation of the *Sp1* gene \[[@B15]\]. Partially consistent with the previous studies \[[@B32]\], CMCs treated with the PI3K inhibitor LY294002 inhibited *Sp1* activity and suppressed CSE synthesis. However, contrary to existing hypotheses, knockdown of *Sp1* also inhibited the phosphorylation of PI3K and Akt, the upstream regulators of *Sp1* \[[@B15]\]. Furthermore, knockdown of *Sp1* gene dramatically decreased the expression of CSE, which led to the suppression of H~2~S production, in spite of its effect on PI3K/Akt signalling. We concluded that the change in activity in PI3K/Akt/*Sp1* signalling is closely associated with the effect of H~2~S in SAP and this underlying mechanism needs to be further explored.

In conclusion, the current study demonstrated that H~2~S played an inhibitory role in intestinal motility of rats with SAP and promoted an inflammatory response during SAP. The production of H~2~S was induced by the inflammation-mediated activation of the PI3K/Akt/*Sp1* pathway. Our preliminary data indicate a role of H~2~S in the pathogenesis of SAP and provide potential leads for the discovery of a novel treatment against SAP.
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